AUTL compared with CLPT: revenue, margins and what each company keeps, and the suppliers and customers both name

AUTLAutolus Therapeutics plc

Mkt capRevenueRevenue

CLPTClearPoint Neuro, Inc.

Mkt capRevenueRevenue

Compare

AUTLAutolus Therapeutics plc

CLPTClearPoint Neuro, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AUTL 4

MRNAModernacustomer

BNTXBioNTechcustomer

—Miltenyi Biotec GmbHunlistedsupplier

—University College of London Businessunlistedsupplier

Shared 0

No disclosed counterparties: CLPT.

Only CLPT 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

AUTLAutolus Therapeutics plc

1.42· pre 1.42· delayed

Mkt cap$404.6MRevenue$46MQ2 FY26Revenue$75MFY25

CLPTClearPoint Neuro, Inc.

9.95· pre 9.95· delayed

Pre-marketNov 3 '26delayed

Mkt cap$342.0MRevenue$12MQ3 FY26Revenue$37MFY25

Compare

Pre-marketNov 3 '26delayed

AUTLAutolus Therapeutics plc

CLPTClearPoint Neuro, Inc.

1.42pre 1.42delayed

Price

9.95pre 9.95delayed

$404.6M

Mkt cap

$342.0M

Q2 FY26$46M

Revenue

$12MQ3 FY26

FY25$75M

Revenue

$37MFY25

AUTL1.42vsCLPT9.95Pre-marketNov 3 '26delayed